4//SEC Filing
Hager Jeffrey 4
Accession 0001567619-19-015228
CIK 0001676725other
Filed
Jul 25, 8:00 PM ET
Accepted
Jul 26, 12:50 PM ET
Size
10.6 KB
Accession
0001567619-19-015228
Insider Transaction Report
Form 4
Hager Jeffrey
SVP, Chief Technology Officer
Transactions
- Exercise/Conversion
Common Stock
2019-06-19$4.31/sh+8,628$37,187→ 115,511 total - Exercise/Conversion
Common Stock
2019-07-10$4.31/sh+7,145$30,795→ 122,656 total - Exercise/Conversion
Stock Option (right to buy)
2019-06-19−8,628→ 40,420 totalExercise: $4.31Exp: 2028-02-26→ Common Stock (8,628 underlying) - Exercise/Conversion
Stock Option (right to buy)
2019-07-10−7,145→ 33,275 totalExercise: $4.31Exp: 2028-02-26→ Common Stock (7,145 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option vest on the first anniversary measured from February 27, 2018 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.
Documents
Issuer
IDEAYA Biosciences, Inc.
CIK 0001676725
Entity typeother
Related Parties
1- filerCIK 0001777424
Filing Metadata
- Form type
- 4
- Filed
- Jul 25, 8:00 PM ET
- Accepted
- Jul 26, 12:50 PM ET
- Size
- 10.6 KB